Remi Gaston-Dreyfus
Director/Board Member at BIONIK LABORATORIES CORP.
Net worth: 689 550 $ as of 30/09/2023
Profile
Remi Gaston-Dreyfus is the founder of RGD Investissements SAS (founded in 2007) where he holds the title of Chief Executive Officer, and Linkinvax SA (founded in 2020) where he holds the title of Director.
Mr. Gaston-Dreyfus's current jobs include Chairman & Chief Executive Officer at GDG Investissemts (since 2007), Independent Director at Bionik Laboratories Corp.
(since 2017), and Director at BIONIK, Inc. (since 2017).
Mr. Gaston-Dreyfus's former job was as a Director at Christie's International Plc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIONIK LABORATORIES CORP
14.89% | 13/06/2023 | 1,858,651 ( 14.89% ) | 687 701 $ | 30/09/2023 |
| 30/09/2019 | 4,997 ( 1.83% ) | 1 849 $ | 30/09/2023 |
Remi Gaston-Dreyfus active positions
| Companies | Position | Start |
|---|---|---|
| BIONIK LABORATORIES CORP. | Director/Board Member | 01/09/2017 |
RGD Investissements SAS
 RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Chief Executive Officer | 01/01/2007 |
BIONIK, Inc.
 BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The private company is based in Watertown, MA. The company was founded by Michael Prywata. | Director/Board Member | 01/09/2017 |
GDG Investissemts
 GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The private company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Chief Executive Officer | 01/01/2007 |
Linkinvax SA
 Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Founder | 01/01/2020 |
Former positions of Remi Gaston-Dreyfus
| Companies | Position | End |
|---|---|---|
Christie's International Plc
 Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIONIK LABORATORIES CORP. | Health Technology |
| Private companies | 5 |
|---|---|
Christie's International Plc
Christie's International Plc Specialty StoresRetail Trade Christie's International Plc provides art business services with global auction sales. Its services include corporate collections, heritage and taxation, storage, museum, and private sales, as well as estates, appraisals, and valuations. The firm serves in the areas of fine and decorative arts, jewelry, photographs, collectibles and wines. The company was founded by James Christie in 1766 and is headquartered in London, the United Kingdom. | Retail Trade |
GDG Investissemts
GDG Investissemts Real Estate DevelopmentFinance Part of GD Holding SARL, GDG Investissements is a real estate investment company based in Paris, France. GDG Investissements is a multidisciplinary team of professionals who work together to deliver high-quality, high-performance real estate assets. The French company specializes in the renovation and restructuring of real estate assets. The private company was founded in 2006. Remi Gaston-Dreyfus has been the CEO of the company since 2007. | Finance |
BIONIK, Inc.
BIONIK, Inc. Industrial MachineryProducer Manufacturing Part of Bionik Laboratories Corp., BIONIK, Inc. designs, develops and markets robotic tools for neurorehabilitation professionals, and patients and their families. The private company is based in Watertown, MA. The company was founded by Michael Prywata. | Producer Manufacturing |
RGD Investissements SAS
RGD Investissements SAS Miscellaneous Commercial ServicesCommercial Services RGD Investissements SAS provides business and management consulting services. The private company is based in Paris, France. The French company was founded by Remi Gaston-Dreyfus. Remi Gaston-Dreyfus has been the CEO since incorporation. | Commercial Services |
Linkinvax SA
Linkinvax SA Miscellaneous Commercial ServicesCommercial Services Linkinvax SA is a French company founded in 2020 by Remi Gaston-Dreyfus, Yves Lévy, André-Jacques Auberton-Hervé, Laurent Hanot, and Mireille Centlivre. The company is based in Paris, France. Linkinvax is developing an innovative protein-based vaccine platform that can accelerate the availability of vaccines by leveraging the research conducted at the Vaccine Research Institute (VRI). The platform is DC targeting-based and can adapt to changes and mutations in the target pathogens. Linkinvax aims to revolutionize vaccine development, particularly for new viruses like Chlamydia and COVID-19. The company is led by André-Jacques Auberton-Hervé, who has been the CEO since 2020. | Commercial Services |
- Stock Market
- Insiders
- Remi Gaston-Dreyfus
